Yahoo Web Search

Sign In

Search results

  1. www.illumina.comIllumina | Sequencing and array solutions to fuel genomic...

    Jun 26, 2024 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

  2. en.wikipedia.org › wiki › Illumina,_IncIllumina, Inc. - Wikipedia

    Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

  3. www.linkedin.com › company › illuminaIllumina | LinkedIn

    Illumina | 470,415 followers on LinkedIn. Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic ...

  4. www.illumina.com › company › careersCareers | Biotech and genomics job opportunities - Illumina

    By nurturing an inclusive and caring environment, we magnify the unique talents of our individuals, bringing forward the best of the collective. 90% of employees are proud to work for Illumina. 23% of new hires are referred by Illumina employees. 41% women in leadership globally.

  5. investor.illumina.com › investors › defaultIllumina, Inc. - Investors

    Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments.

  6. investor.illumina.com › news › press-release-detailsIllumina, Inc. - Illumina acquires Fluent BioSciences to...

    Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.

  7. investor.illumina.com › news › press-release-detailsIllumina, Inc. - Illumina delivers 2021 results ahead of...

    Jan 10, 2022 · The company expects another strong year in 2022, with consolidated revenue guidance of $5.15 billion to $5.24 billion, or growth of 14% to 16% year-over-year, as sequencing awareness, demand, and adoption increase.

  8. finance.yahoo.com › news › illumina-acquires-fluent-biosciences-accelerateIllumina acquires Fluent BioSciences to accelerate single-cell...

    Jul 9, 2024 · Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and ...

  9. finance.yahoo.com › quote › ILMNIllumina, Inc. (ILMN) Stock Price, News, Quote & History - Yahoo...

    Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.

  10. sg.linkedin.com › company › illuminaIllumina | LinkedIn

    Illumina | 470,224 followers on LinkedIn. Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic...